Double-Blind Switch Study of Vilazodone in the Treatment of Major Depressive Disorder Following Partial Response to or Inability to Tolerate a Generic SSRI
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2017
At a glance
- Drugs Vilazodone (Primary) ; Citalopram
- Indications Major depressive disorder
- Focus Therapeutic Use
- 19 Apr 2016 Status changed from recruiting to completed.
- 01 May 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 09 Jan 2013 New trial record